[go: up one dir, main page]

WO2002005827A3 - Use of natural products in cancer treatment - Google Patents

Use of natural products in cancer treatment Download PDF

Info

Publication number
WO2002005827A3
WO2002005827A3 PCT/GB2001/003150 GB0103150W WO0205827A3 WO 2002005827 A3 WO2002005827 A3 WO 2002005827A3 GB 0103150 W GB0103150 W GB 0103150W WO 0205827 A3 WO0205827 A3 WO 0205827A3
Authority
WO
WIPO (PCT)
Prior art keywords
cancer treatment
natural products
cancer
isoflavones
micronutrients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2001/003150
Other languages
French (fr)
Other versions
WO2002005827A2 (en
Inventor
Paul Rodney Clayton
Harcharan Rooperai
David Dexter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FORUM BIOSCIENCE
Original Assignee
FORUM BIOSCIENCE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0017620A external-priority patent/GB0017620D0/en
Priority claimed from GB0023574A external-priority patent/GB0023574D0/en
Priority claimed from GB0026600A external-priority patent/GB0026600D0/en
Application filed by FORUM BIOSCIENCE filed Critical FORUM BIOSCIENCE
Priority to AU2001276462A priority Critical patent/AU2001276462A1/en
Publication of WO2002005827A2 publication Critical patent/WO2002005827A2/en
Publication of WO2002005827A3 publication Critical patent/WO2002005827A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A programme of micronutrients designed specifically to modify all the known steps in the cancer sequence comprises administering an effective amount of one or more flavonoids, one or more lectins, one or more isoflavones, one or more carotenoids, betaine and selenium to a mammal suffering from cancer as a combination therapy in which the components are administered together, concurrently or sequentially.
PCT/GB2001/003150 2000-07-18 2001-07-18 Use of natural products in cancer treatment Ceased WO2002005827A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001276462A AU2001276462A1 (en) 2000-07-18 2001-07-18 Use of natural products in cancer treatment

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0017620A GB0017620D0 (en) 2000-07-18 2000-07-18 Flavonoids in cancer treatment
GB0017620.6 2000-07-18
GB0023574.7 2000-09-26
GB0023574A GB0023574D0 (en) 2000-09-26 2000-09-26 Use of natural products in cancer treatment
GB0026600A GB0026600D0 (en) 2000-10-31 2000-10-31 Use of natural products in cancer treatment
GB0026600.7 2000-10-31

Publications (2)

Publication Number Publication Date
WO2002005827A2 WO2002005827A2 (en) 2002-01-24
WO2002005827A3 true WO2002005827A3 (en) 2002-07-18

Family

ID=27255810

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/003150 Ceased WO2002005827A2 (en) 2000-07-18 2001-07-18 Use of natural products in cancer treatment

Country Status (2)

Country Link
AU (1) AU2001276462A1 (en)
WO (1) WO2002005827A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060020046A1 (en) * 2002-02-15 2006-01-26 Dms Ip Assets B.V. Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
FR2836046B1 (en) * 2002-02-15 2006-09-15 Marie Jose Touche NOVEL THERAPEUTIC APPLICATION OF COMPOUND A: BUTOFORM OR SCUROFORM ASSOCIATED WITH PRODUCT B: EUGENOL AND PRODUCT C: ZINC OXIDE, ADDED TO LYCOPENE
DE10310196A1 (en) * 2003-03-06 2004-09-23 Rina-Netzwerk Rna Technologien Gmbh Use a tricyclic antidepressant to promote endocytosis
US9597311B2 (en) * 2005-09-27 2017-03-21 Robert Benson Aylor Suppression and prevention of tumors
EP2260856A1 (en) 2009-05-12 2010-12-15 URSAPHARM Arzneimittel GmbH Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc
EP3153160B1 (en) * 2015-10-08 2021-08-11 Chuen Wei Lu Use of xanthophylls for the treatment of cancers
US9572783B1 (en) 2015-10-08 2017-02-21 Chuen Wei Lu Use of xanthophylls for the treatment of cancers

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4111208A1 (en) * 1991-04-06 1992-10-08 Inge Witte MEDICINES FOR THE TREATMENT OF CANCER AND CARE PRODUCTS FOR THE CANCER-INFECTED PARTIES
EP0627173A1 (en) * 1993-05-31 1994-12-07 GIULIANI S.p.A. Preparation for dietetic use or as a food supplement, with targeted release in the colon
WO1995021542A1 (en) * 1994-02-08 1995-08-17 Vioryl Chemical And Agricultural Industry, Research S.A. A natural and healthy juice
WO1999007400A1 (en) * 1997-08-06 1999-02-18 Melaleuca, Incorporated Dietary supplements containing natural ingredients
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
WO2001019383A1 (en) * 1999-09-17 2001-03-22 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
WO2001085183A2 (en) * 2000-05-08 2001-11-15 N.V. Nutricia Preparation for the prevention and treatment of ocular disorders

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4111208A1 (en) * 1991-04-06 1992-10-08 Inge Witte MEDICINES FOR THE TREATMENT OF CANCER AND CARE PRODUCTS FOR THE CANCER-INFECTED PARTIES
EP0627173A1 (en) * 1993-05-31 1994-12-07 GIULIANI S.p.A. Preparation for dietetic use or as a food supplement, with targeted release in the colon
WO1995021542A1 (en) * 1994-02-08 1995-08-17 Vioryl Chemical And Agricultural Industry, Research S.A. A natural and healthy juice
WO1999007400A1 (en) * 1997-08-06 1999-02-18 Melaleuca, Incorporated Dietary supplements containing natural ingredients
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
WO2001019383A1 (en) * 1999-09-17 2001-03-22 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
WO2001085183A2 (en) * 2000-05-08 2001-11-15 N.V. Nutricia Preparation for the prevention and treatment of ocular disorders

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CARROLL K K ET AL: "ANTICANCER PROPERTIES OF FLAVONOIDS, WITH EMPHASIS ON CITRUS FLAVONOIDS", ANTIOXIDANTS IN HEALTH AND DISEASE, MARCEL DEKKER, NEW YORK, NY,, US, vol. 7, 1998, pages 437 - 446, XP000960909, ISSN: 1521-4486 *
COMBS G F JR ET AL: "Reduction of cancer mortality and incidence by selenium supplementation", MEDIZINISCHE KLINIK, XX, XX, vol. 92, no. SUPPL 3, 1997, pages 42 - 45, XP002123911 *
FRANKEL E N: "NUTRITIONAL BENEFITS OF FLAVONOIDS", FOOD FACTORS FOR CANCER PREVENTION, XX, XX, 1997, pages 613 - 616, XP000886654 *
MOULY PIERRE P ET AL: "Determination of the geographical origin of valencia orange juice using carotenoid liquid chromatographic profiles.", JOURNAL OF CHROMATOGRAPHY A, vol. 844, no. 1-2, 4 June 1999 (1999-06-04), pages 149 - 159, XP004170302, ISSN: 0021-9673 *
SO F V ET AL: "INHIBITION OF HUMAN BREAST CANCER CELL PROLIFERATION AND DELAY OF MAMMARY TUMORIGENESIS BY FLAVONOIDS AND CITRUS JUICES", NUTRITION AND CANCER, LONDON, GB, vol. 26, no. 2, 1996, pages 167 - 181, XP000938970, ISSN: 0163-5581 *

Also Published As

Publication number Publication date
AU2001276462A1 (en) 2002-01-30
WO2002005827A2 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
WO2003055527A3 (en) Immunoconjugates useful for treatment of tumours
HUP0400231A3 (en) Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
EP1355563A4 (en) METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
EP1816996A4 (en) Methods and therapeutic compositions comprising plant extracts for the treatment of cancer
WO2001052921A3 (en) Valve arrangement
WO2001092581A3 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2003273182A1 (en) Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
WO2004080284A3 (en) Antibody-targeted photodynamic therapy
WO2000013712A3 (en) Methods and compositions for the prevention or treatment of cancer
WO2002005827A3 (en) Use of natural products in cancer treatment
IL158206A0 (en) Compositions and methods for the prevention and treatment of human prostate cancer
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
WO2003013560A1 (en) Herbal composition for treatment of chronic renal failure and method to produce thereof
BRPI0518250A2 (en) anticancer treatments
WO2002087604A3 (en) Preparations containing a combination of vitamin e and afamin
EP1234585A3 (en) Methods and compositions for the prevention or treatment of cancer
WO1999034785A3 (en) Treatment of dyskinesias
WO2001091771A3 (en) Compositions for treating back and leg discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
WO2002024179A3 (en) Method for reducing toxicity of combined chemotherapies
AU2003219664A1 (en) Methods and therapeutic compositions in the treatment of advanced cancer
AU2002246308A1 (en) Herbal formulation for treating attention defienciency disorder (add/adht) and process for preparation
WO2005062810A3 (en) Treatment of primary and metastatic neoplastic diseases with tetraarsenic decaoxide
AU2003280341A1 (en) Synergistic combinations of dietary fiber and n-saids for the treatment of cancer
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
WO2002030433A3 (en) Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: JP